Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica. (Q51029416)
Jump to navigation
Jump to search
scientific article published in February 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica. |
scientific article published in February 2004 |
Statements
1 reference
Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica. (English)
1 reference
Mark Schiffman
1 reference
Robert D Burk
1 reference
Raphael P Viscidi
1 reference
Allan Hildesheim
1 reference
Philip E Castle
1 reference
Sophia Wang
1 reference
Rolando Herrero
1 reference
Maria C Bratti
1 reference
Ana Cecilia Rodriguez
1 reference
Mark E Sherman
1 reference
Barbara Clayman
1 reference
1 February 2004
1 reference
13
1 reference
324-327
1 reference
2
1 reference
Identifiers
1 reference